zlacker

>>giulio+(OP)
>The share of U.S. households reporting at least one user rose from about 11% in late 2023 to more than 16% by mid-2024.

I was wondering how you could get such a high impact overall. But it seems one in 6 households are on GLP-1 drugs in the US.

In my friend circle in Germany I don't even know one single person on this stuff.

It's insane to me that so many people need these to get off the processed foods killing them in the US.

>>carlmr+B5
For artificial problems, artificial solutions. I think the state of food in the US is really bad, and one cannot compare such products to the superior EU food quality standards and eating habits (and city designs) which render the incentives really perverse

>>u_sama+h6
These drugs are expensive and, at least in France, they're discussing offering them. I think this is the main reason explaining the difference in prevalence between the US and the EU.

Despite access to "superior food quality", weight issues are absolutely a problem in the EU, too. Maybe it's not at the same point as in the US, but 51% of the population of the EU (outside Ireland and Germany for some reason) are "overweight or obese" [0].

---

[0] https://drees.solidarites-sante.gouv.fr/publications-communi... In French, from the ministry of health, but there's a chart which should be clear enough for everybody.